Washington, DC 20006-5349
HELPLINE
Pneumonitis is a serious treatment-related side-effect of both radiation, immunotherapy and some chemotherapies. This episode of MesoTV includes discussion on diagnosis, treatment and the dilemma…
As Father’s Day approaches, many in the meso community will be honoring, and in some cases remembering, the fathers in their lives. In this spirit,…
The National Cancer Institute, part of the National Institutes of Health in Bethesda, Maryland, is working toward developing new protocols for improved treatment for peritoneal…
Immunotherapy may utilize the body’s own immune system to fight the cancer, but that does not mean that it comes free of side-effects. What are…
Dr. Melissa Johnson of the Sarah Cannon Cancer Center in Nashville, TN talks to us about a multi-center clinical trial utilizing engineered t-cell therapy similar…
This episode of MesoTV tackles the topic of managing pain caused by mesothelioma or its treatment. Four experts from the Baylor College of Medicine discuss pain management and ways mesothelioma patients…
The International Mesothelioma Interest Group (iMig) biannual meeting kicked off in earnest today with its 2021 virtual program. The conference was initially slated to take…
A phase 3 randomized clinical trial looking into the efficacy of combination chemotherapy with immunotherapy is now open in the United States and Australia. How…
Garrett Nash, MD, discusses peritoneal and benign presentations of mesothelioma and their respective treatment. Dr. Nash is a surgical oncologist at Memorial Sloan Kettering Cancer…
Below, Dr. Taylor Ripley, a thoracic surgeon at Baylor and a member of the board of directors of the Mesothelioma Applied Research Foundation, takes a…
